Sofinnova Ventures »

Cooper Cos shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Cooper Cos (COO) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Cooper Cos

Tip: Access up to 7 years of quarterly data

All positions including Cooper Cos held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cooper Cos by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 21k 101.46

More positions owned by Sofinnova Ventures

Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Natera (NTRA)
Edwards Lifesciences (EW)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Novo-Nordisk A S Adr (NVO)
Stryker Corporation (SYK)
AstraZeneca Sponsored Adr (AZN)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Align Technology (ALGN)
Alnylam Pharmaceuticals (ALNY)
Rapport Therapeutics
Syndax Pharmaceuticals (SNDX)
Elanco Animal Health (ELAN)

View all positions for Sofinnova Ventures

Top funds holding Cooper Cos

Vanguard Group
BlackRock
State Street Corporation
Kayne Anderson Rudnick Investment Management
T. Rowe Price Investment Management
Capital World Investors
Alliancebernstein
Geode Capital Management
Veritas Asset Management
Jpmorgan Chase & Co
Generation Investment Management
Invesco
Henderson Group
Victory Capital Management
Macquarie Group

View all funds holding Cooper Cos